BACKGROUND In some studies @entity29 ( @entity29 ) and @entity1593 were considered to be associated and some belive that this association may influence the prognosis of @entity29 . However, there is a cosiderable controversy regarding this association. Therefore ,we aimed to assess the association of these two common digestive diseases and evaluate the complications of this association. METHODS In this comparative study, 200 @entity1 with @entity1960 ( @entity1960 ) and 206 @entity1 with @entity30 ( @entity30 ) were evaluated for @entity1593 using relevant diagnostic tests and pathologic studies. Total IgA, IgA tissue transgulaminase antibody and specific IgA anti endomysial antibody were asseyed. In cases of @entity7491 , total IgG and IgG tissue TG and IgG anti endomyseal Ab were measured. @entity1 with increased specific IgA and IgG antibodies for @entity1593 , underwent endoscopy and 4 standard samples were obtained. Our results were compared with the results of the prevalence study of @entity1593 in the general population. Data were analyzed using analytic and descriptive statistics at a significance level of 5%. RESULTS Among the studied @entity1 , 1 @entity1 with @entity1960 had elevated IgA anti tTG antibody and IgA anti-endomysial antibody who underwent endoscopy and celiac was confirmed on pathology. Hence, of the 200 patientswith @entity1960 , the diagnosis of @entity1593 was confirmed in 1 @entity1 (1:200) with no significant difference with the prevalence of @entity1593 in the general population (1:166). However, none of our @entity1 with @entity30 had @entity1593 (0:206). CONCLUSION We found no significant difference in the prevalence of @entity1593 between @entity1 with @entity1960 and the general population. Since most of our @entity1 had a mild level of Crohn's activation, none of those with @entity30 had @entity1593 . Complications of @entity29 including sclerosing @entity255 , may be more common in @entity1 with concurrent @entity1593 . Therefore, it is recommended that @entity1593 be considered in @entity1 with severe and complicated @entity29 .

Is the Prevalence of XXXX Higher than the General Population in Inflammatory Bowel Diseaese?

@entity1 :: ('9606', 'Species') :: ['participants', 'Patients', 'patients', 'patient'] @entity1593 :: ('MESH:D002446', 'Disease') :: ['celiac disease'] @entity29 :: ('MESH:D015212', 'Disease') :: ['inflammatory bowel disease', 'IBD'] @entity1960 :: ('MESH:D003092', 'Disease') :: ['ulceritive colitis', 'UC'] @entity7491 :: ('MESH:D017098', 'Disease') :: ['IgA deficiency'] @entity30 :: ('MESH:D003424', 'Disease') :: ['CD', "Crohn's disease"] @entity255 :: ('MESH:D002761', 'Disease') :: ['cholangitis']
@entity1593 :: (MESH:D002446,Disease) :: ['Celiac Disease']
